A new disclosure filed with the U.S. House of Representatives shows that Rep. Julia Letlow sold shares of Amgen Inc. (AMGN) common stock on November 19, 2024. The transaction was made personally by the member of Congress and was reported in the $1,001 to $15,000 range, the smallest disclosure bracket under the STOCK Act’s reporting rules.
The sale was executed through a Merrill Lynch Investment Account, identified in the filing as Account #025, which appears to be a brokerage account used for this and potentially other holdings.
A Late Filing
Under the STOCK Act, members of Congress are required to publicly disclose stock transactions within 45 days of execution. In this case, the periodic transaction report was filed 265 days after the November 19 sale date, well beyond that statutory window. The filing does not include an explanation for the delay, and whoisbuyingnow.com is not speculating as to the cause. Late filings are a recurring feature of congressional stock disclosures generally and are not, on their own, evidence of any wrongdoing.
This is not the first time Letlow’s AMGN activity has come with a delayed filing. Our previous coverage documented an earlier purchase of the same stock that was reported 292 days after the transaction date, suggesting a pattern of delayed reporting tied to this particular holding.
Amgen is a large biotechnology company traded on the Nasdaq under the ticker AMGN, and it is held widely across both institutional and individual portfolios. The size of this particular sale, capped at $15,000, places it among the smaller transactions disclosed by members of Congress, though the exact dollar amount is not required to be specified under STOCK Act rules, only the applicable range.
Periodic transaction reports like this one are part of a broader transparency framework meant to allow the public to track potential conflicts of interest between congressional duties and personal financial activity. They do not indicate that any law was broken, nor do they suggest the timing of the trade was connected to any legislative or committee action. whoisbuyingnow.com compiles these filings as they become available to give readers a clear record of disclosed activity without drawing conclusions about intent.
Readers interested in broader portfolio tracking beyond individual congressional filings can also review institutional holdings data, such as the quarterly 13F filings covered in our profile of Ossiam’s tracked portfolio moves.